Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
Supernus Pharmaceuticals has a consensus price target of $36.00.
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $35.4305 last updated December 20, 2024 at 4:01 PM EST.
There are no upcoming dividends for Supernus Pharmaceuticals.
Supernus Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Supernus Pharmaceuticals.
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.